Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barton

Showing results (271-280 of 297) with videos related to

Pageof 30
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2020
A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 24, 2020
Correction: A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Annals of the Rheumatic Diseases|May 1, 2019
Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for <i>CD40</i> and CD39Athina Spiliopoulou, Marco Colombo, Darren Plant, et al.
The Lancet. Rheumatology|January 22, 2024
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsFelice Rivellese, Alessandra Nerviani, Giovanni Giorli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid ArthritisJing Cui, Dorothee Diogo, Eli A Stahl, et al.
Arthritis Research & Therapy|April 18, 2015
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only studyAriana Montes, Eva Perez-Pampin, Federico Navarro-Sarabia, et al.
The Pharmacogenomics Journal|May 26, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsJohn C Taylor, Tim Bongartz, Jonathan Massey, et al.
Annals of the Rheumatic Diseases|December 13, 2012
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritisMaša Umiċeviċ Mirkov, Jing Cui, Sita H Vermeulen, et al.
Nature Genetics|November 13, 2012
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritisSteve Eyre, John Bowes, Dorothée Diogo, et al.
Plos Genetics|November 13, 2012
Informed conditioning on clinical covariates increases power in case-control association studiesNoah Zaitlen, Sara Lindström, Bogdan Pasaniuc, et al.
Pageof 30

Showing results (271-280 of 297) with videos related to

Sort By:
Pageof 30
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2020
A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 24, 2020
Correction: A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndromeSara Cuvertino, Verity Hartill, Alice Colyer, et al.
Annals of the Rheumatic Diseases|May 1, 2019
Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for <i>CD40</i> and CD39Athina Spiliopoulou, Marco Colombo, Darren Plant, et al.
The Lancet. Rheumatology|January 22, 2024
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsFelice Rivellese, Alessandra Nerviani, Giovanni Giorli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid ArthritisJing Cui, Dorothee Diogo, Eli A Stahl, et al.
Arthritis Research & Therapy|April 18, 2015
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only studyAriana Montes, Eva Perez-Pampin, Federico Navarro-Sarabia, et al.
The Pharmacogenomics Journal|May 26, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsJohn C Taylor, Tim Bongartz, Jonathan Massey, et al.
Annals of the Rheumatic Diseases|December 13, 2012
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritisMaša Umiċeviċ Mirkov, Jing Cui, Sita H Vermeulen, et al.
Nature Genetics|November 13, 2012
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritisSteve Eyre, John Bowes, Dorothée Diogo, et al.
Plos Genetics|November 13, 2012
Informed conditioning on clinical covariates increases power in case-control association studiesNoah Zaitlen, Sara Lindström, Bogdan Pasaniuc, et al.
Pageof 30